Back to Freepaper Session

Three years follow-up after implantation of iris claw family intraocular lens in phakic eyes by a novel surgeon

Session Details

Session Title: Phakic IOL Implantation II

Session Date/Time: Wednesday 09/10/2013 | 08:00-10:30

Paper Time: 08:00

Venue: E104-105 (First Floor)

First Author: : J.Cazal SPAIN

Co Author(s): :    F. Sanchez Fabo              

Abstract Details

Purpose:

To evaluate the safety, efficacy, predictability, stability, and complications of the foldable Artiflex Toric iris-fixated intraocular lens and Artisan Toric (Ophtec BV, Groningen, The Netherlands) for the correction of myopia and astigmatism in phakic eyes

Setting:

Centro Oftalmológico del Bages, Manresa,Spain

Methods:

All eyes underwent implantation of the foldable iris-fixated Artiflex phakic intraocular lens (PIOL) with an optic zone of 6 mm. The follow-up was 3 years. Phakic intraocular lenses were implanted in powers ranging from -6.0 to -14.0 D.

Results:

After 3 years, a UCVA of 20/40 or better was observed in 96.2% of eyes. The BSCVA was 20/40 or better in all eyes. A gain of 1 line or more of BSCVA was found in 40.9% of eyes, and none lost 2 or more lines. The mean endothelial cell change was -0.05%, 1.89%, and -2.7% at 6 months, 1 year, and 2 years,respectively. Chronic inflammation was not detected in any eye by slit-lamp biomicroscopy, nor did any eye develop angle closure or glaucoma.

Conclusions:

After 3 years of follow-up results suggest that the Artisan/Artiflex ™ lens is an accurate and safe method for the correction of myopia and astigmatism. Surgical skill is important but could be performed by novel surgeons. Longer-term data are needed to assess the impact of the lens on the endothelium, the crystalline lens, and the iris

Financial Interest:

NONE